Chuan‐Ming Xie

1.7k total citations
42 papers, 1.3k citations indexed

About

Chuan‐Ming Xie is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Chuan‐Ming Xie has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Chuan‐Ming Xie's work include Ubiquitin and proteasome pathways (14 papers), Autophagy in Disease and Therapy (8 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Chuan‐Ming Xie is often cited by papers focused on Ubiquitin and proteasome pathways (14 papers), Autophagy in Disease and Therapy (8 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Chuan‐Ming Xie collaborates with scholars based in China, Hong Kong and United States. Chuan‐Ming Xie's co-authors include Christopher H.K. Cheng, Sidney Yu, Jia Li, Wood Yee Chan, Jun Zhao, Xiaoyu Liu, Kathy W. Y. Sham, Fajun Nan, Jing-Ya Li and Zhe Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Free Radical Biology and Medicine.

In The Last Decade

Chuan‐Ming Xie

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by Chuan‐Ming Xie

Since Specialization

Citations

This map shows the geographic impact of Chuan‐Ming Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan‐Ming Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan‐Ming Xie more than expected).

Fields of papers citing papers by Chuan‐Ming Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan‐Ming Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan‐Ming Xie. The network helps show where Chuan‐Ming Xie may publish in the future.

Co-authorship network of co-authors of Chuan‐Ming Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan‐Ming Xie. A scholar is included among the top collaborators of Chuan‐Ming Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan‐Ming Xie. Chuan‐Ming Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression 2025 ·Nature Communications ·(unknown), Hongqiang Yu, (unknown), Yuanhang Ma, (unknown), (unknown), (unknown), (unknown), Ying Wu, Ping Zheng, (unknown), (unknown), Fengtian He, Leida Zhang, Chuan‐Ming Xie, Haojun Xiong	2
2	Macrophage miR-4524a-5p/TBP promotes β-TrCP -TIM3 complex activation and TGFβ release and aggravates NAFLD-associated fibrosis 2025 ·Cell Death and Disease ·(unknown), Lei Fang, Xingxing Su, Jie Zhang, Haojun Xiong, Hongqiang Yu, (unknown), Xiaotong Lin, Min Ke, Di Wu, Zhiyu Chen, Jian-Ping Gong, Chuan‐Ming Xie	3
3	Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma 2024 ·Experimental & Molecular Medicine ·Xun Li, Chengcheng Zhang, Xiaotong Lin, Jie Zhang, Yujun Zhang, Hongqiang Yu, Zeyu Liu, Yi Gong, (unknown), Chuan‐Ming Xie	11
4	FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration 2023 ·Frontiers in Oncology ·Chunming Li, Jie Zhang, Wu Wu, Zhu Zhu, Feng Li, Di Wu, Xiaojun Wang, Chuan‐Ming Xie, (unknown)	7
5	Silencing of FAM111B inhibited proliferation, migration and invasion of hepatoma cells through activating p53 pathway 2023 ·Digestive and Liver Disease ·Feng Li, Hongye He, (unknown), (unknown), Yi Gong, Qiang Wang, Haojun Xiong, Chuan‐Ming Xie, (unknown)	6
6	FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males 2023 ·Cancer Letters ·Zeyu Liu, Xiaotong Lin, Yujun Zhang, (unknown), Hongqiang Yu, Lei Fang, Chunming Li, Di Wu, (unknown), Chuan‐Ming Xie	14
7	Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis 2023 ·Journal of Molecular Cell Biology ·Ye Tan, Di Wu, Zeyu Liu, Hongqiang Yu, Xiangru Zheng, Xiaotong Lin, (unknown), (unknown), Chuan‐Ming Xie	5
8	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice 2023 ·Cell Reports ·Xiaotong Lin, Jie Zhang, Zeyu Liu, Di Wu, Lei Fang, Chunming Li, Hongqiang Yu, Chuan‐Ming Xie	10
9	An optimized protocol to detect protein ubiquitination and activation by ubiquitination assay in vivo and CCK-8 assay 2023 ·STAR Protocols ·Xiaotong Lin, Jie Zhang, Chuan‐Ming Xie	1
10	Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling 2022 ·Theranostics ·Yuandeng Luo, Xiaoyu Liu, Lei Fang, Hongqiang Yu, Yujun Zhang, Min Chen, (unknown), Chuan‐Ming Xie	16
11	Elevated Sodium Pump α3 Subunit Expression Promotes Colorectal Liver Metastasis via the p53-PTEN/IGFBP3-AKT-mTOR Axis 2021 ·Frontiers in Oncology ·Di Wu, Hongqiang Yu, Haojun Xiong, Yujun Zhang, Xiaotong Lin, Jie Zhang, Wu Wu, Teng Wang, Xiaoyu Liu, Chuan‐Ming Xie	4
12	p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma 2020 ·Journal of Hepatology ·Yuandeng Luo, Lei Fang, Hongqiang Yu, Jie Zhang, Xiaotong Lin, Xiaoyu Liu, Di Wu, (unknown), Huang Deng, Yujun Zhang, Shu Chen, Yan Jiang, Ling Shuai, Yu He, (unknown), Ping Bie, Chuan‐Ming Xie	61
13	The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways 2019 ·Cell Reports ·Chuan‐Ming Xie, Mingjia Tan, Xiaotong Lin, Di Wu, (unknown), Ye Tan, Haomin Li, Yuanyuan Ma, Xiufang Xiong, Yi Sun	36
14	Cardiac glycosides block cancer growth through HIF-1α- and NF-κB-mediated Plk1 2013 ·Carcinogenesis ·Chuan‐Ming Xie, Xiaoyu Liu, Sidney Yu, Christopher H.K. Cheng	28
15	Novel microtubule-targeted agent 6-chloro-4-(methoxyphenyl) coumarin induces G2-M arrest and apoptosis in HeLa cells 2012 ·Acta Pharmacologica Sinica ·Yiming Ma, Yubo Zhou, Chuan‐Ming Xie, Dongmei Chen, Jia Li	32
16	Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation 2011 ·Free Radical Biology and Medicine ·Chuan‐Ming Xie, Wood Yee Chan, Sidney Yu, Jun Zhao, Christopher H.K. Cheng	217
17	Identification of a Membrane Estrogen Receptor in Zebrafish with Homology to Mammalian GPER and Its High Expression in Early Germ Cells of the Testis1 2009 ·Biology of Reproduction ·Xiaochun Liu, Pei Zhu, Kathy W. Y. Sham, (unknown), Chuan‐Ming Xie, Yong Zhang, Yun Liu, Shuisheng Li, Xigui Huang, Christopher H.K. Cheng, Haoran Lin	75
18	Design, Synthesis, and Biological Evaluation of Caprolactam‐Modified Bengamide Analogues 2007 ·ChemMedChem ·Gang Liu, (unknown), Wanyi Tai, Chuan‐Ming Xie, Yulin Li, Jia Li, Fajun Nan	26
19	Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases 2006 ·Bioorganic & Medicinal Chemistry Letters ·Weigang Huang, Jingya Li, Wei Zhang, Yueyang Zhou, Chuan‐Ming Xie, Yu Luo, Yunfei Li, Jingli Wang, (unknown), (unknown), Wei Lü	28
20	Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK 2006 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Zhe Cheng, Tao Pang, Min Gu, Anhui Gao, Chuan‐Ming Xie, Jing-Ya Li, Fajun Nan, Jia Li	204

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact